Shandong Chengchuang Blue Ocean Pharmaceutical is a professional pharmaceutical R&D enterprise under Chenghui Group. Founded in 1995 and headquartered in Jinan, Shandong Province, we specialize in commissioned R&D of generic drugs. Drawing on 30 years of industry experience, we have delivered over 300 drug R&D projects and secured more than 140 national authorized patents.
We have built an integrated full-industry-chain MAH R&D platform covering pharmaceutical intermediates, APIs and FDFs, supported by robust advantages in the raw material supply chain.
Our R&D platform hosts a high-standard formulation laboratory fitted with state-of-the-art formulation equipment from home and abroad. We focus on therapeutic areas including common and chronic diseases, perioperative care, antivirals, and topical dosage forms, with specialization in developing the dosage forms listed below:
· Oral Solid Dosage Forms: tablets, capsules, granules, dispersible tablets, dry suspensions, orally disintegrating tablets, enteric-coated tablets/capsules, sustained-release tablets/capsules, oral instant films, etc.
· Topical Dosage Forms: ointments, creams, gels, liniments, lotions, patches, pastes, suppositories, etc.
We have established strategic partnerships with multiple top-tier domestic formulation manufacturers to support the commercial production of our FDFs.
We provides entrusted R&D, regulatory registration, technology transfer and contract manufacturing services for APIs and Finished Dosage Forms (FDFs) for domestic and overseas enterprises.
We look forward to potential collaborations!
